FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula (I), where R1 is phenyl substituted with one or more substitutes, each of which is independently selected from a group consisting of halogen, C1-4alkyl, polyhalogen-C1-4alkyl; R2 is C1-4alkyl, aryl or Het; where aryl is phenyl; Het is selected from a group consisting of pyridinyl, pyrazinyl, each of which is optionally substituted with one substitute selected independently from a group consisting of halogen, C1-4alkyl, -NR6aR6b; each of R6a and R6b independently represents hydrogen or C1-4alkyl; R3 is hydrogen; R4 is C1-4alkyl; or a pharmaceutically acceptable salt thereof.
(I).
EFFECT: compounds of the invention are intended for preventing or treating disorders involving metabotropic receptors of mGluR2 subtype.
9 cl, 7 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
6,7-DIHYDROPYRAZOLO[1,5-A]PYRAZINE-4(5H)-ONE COMPOUNDS AND USE THEREOF AS NEGATIVE ALLOSTERIC MODULATORS OF mGluR2 RECEPTORS | 2015 |
|
RU2708391C2 |
6,7-DIHYDROPYRAZOLO[1,5-A]PYRAZINE-4(5H)-ONE COMPOUNDS AND USE THEREOF AS NEGATIVE ALLOSTERIC MODULATORS OF mGluR2 RECEPTORS | 2015 |
|
RU2711382C2 |
1,2,4-TRIAZOLO[4,3-A]PYRIDINE COMPOUNDS AND USE THEREOF AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS | 2015 |
|
RU2695651C2 |
6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZINONE DERIVATIVE AND ITS APPLICATION IN MEDICINE | 2018 |
|
RU2792694C2 |
COMBINATIONS COMPRISING PDE 2 INHIBITORS SUCH AS 1-ARYL-4-METHYL- [1,2,4]TRIAZOLO[4,3-A]QUINOXALINE COMPOUNDS AND PDE 10 INHIBITORS FOR USE IN TREATMENT OF NEUROLOGICAL OR METABOLIC DISORDERS | 2013 |
|
RU2657540C2 |
IMIDAZO[1,2-a]PYRIDINE DERIVATIVES AND THEIR APPLICATION AS POSITIVE ALLOSTERIC MODULATORS OF mGluR2 RECEPTORS | 2008 |
|
RU2492170C2 |
3-AZABICYCLO[3,1,0]HEXYL DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS | 2009 |
|
RU2510396C2 |
INHIBITORS OF PHOSPHODIESTERASE 10 ENZYME | 2013 |
|
RU2667058C2 |
NEW SUBSTITUTED AZAINDOLINE DERIVATIVES AS NIK INHIBITORS | 2018 |
|
RU2780577C2 |
METHOD OF PRODUCING NAPHTHALEN-2-YL-PYRAZOL-3-ONE INTERMEDIATE COMPOUNDS USED IN SYNTHESIS OF SIGMA RECEPTOR INHIBITORS | 2009 |
|
RU2509763C2 |
Authors
Dates
2019-07-31—Published
2015-07-30—Filed